42 cases of male breast cancer were studied. The disease is diagnosed in males at a later stage than in females. The prognosis of this disease in males is more favorable than in females: in stage I there is an 83% 5-year survival, while in stage II there is 62% 5-year survival. Male breast cancer shows a high hormone dependency: 80% of patients arc improved following orchiectomy and 64% following stilbestrol therapy. Data is reported regarding age, family status, community origin, histology, treatment and survival.
- Male breast cancer
- Radiation therapy